Methods for modulating the activity of the mammalian FXR receptor. The methods include methods of treating a hyper- or hypocholesterolemic mammal comprising contacting the mammal with synthetic compounds having FXR receptor activity.
Organosilyl compounds having nuclear hormone receptor modulating activity
申请人:Allergan Sales, LLC
公开号:US06452032B1
公开(公告)日:2002-09-17
Silicone-containing organic compounds useful as modulators of mammalian nuclear hormone receptors, particularly the retinoid receptors and the farnesoid receptors.